KW
AMGN icon

Keyvantage Wealth’s Amgen AMGN Stock Holding History

Keyvantage Wealth’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$476K Sell
1,314
-213
-14% -$72.9K 0.18% 58
2026
Q1 		$537K Buy
1,527
+264
+21% +$94.1K 0.24% 61
2025
Q4 		$413K Buy
1,263
+5
+0.4% +$1.59K 0.18% 68
2025
Q3 		$355K Sell
1,258
-11
-0.9% -$3.19K 0.15% 72
2025
Q2 		$354K Sell
1,269
-103
-8% -$29.2K 0.16% 72
2025
Q1 		$428K Sell
1,372
-98
-7% -$28.9K 0.21% 64
2024
Q4 		$383K Buy
+1,470
New +$436K 0.27% 63

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Keyvantage Wealth's AMGN Position: Q2 2026 in Review

Keyvantage Wealth reduced its Amgen (AMGN) stake by 14% in Q2 2026, selling an estimated $72.9K and leaving 1,314 shares worth $476K. The position accounts for 0.18% of the portfolio, ranked #58.

Keyvantage Wealth first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $537K in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Keyvantage Wealth held 1,314 shares of Amgen worth $476K as of Q2 2026.
  • Keyvantage Wealth sold 213 Amgen shares in Q2 2026, an estimated $72.9K.
  • Amgen made up 0.18% of Keyvantage Wealth's portfolio in Q2 2026, its #58 holding.
  • Keyvantage Wealth first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Keyvantage Wealth's Amgen position peaked at $537K in Q1 2026.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Keyvantage Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.